In September 2025, clinical research was published on weight loss for two oral incretin therapies: an oral version of semaglutide and Orforglipron, also a GLP-1 receptor agonist
Management approaches include increasing fiber intake gradually (too much fiber at once worsens bloating), drinking at least 64 ounces of water daily, taking magnesium citrate (400-600mg at bedtime), and increasing physical activity
HSA/FSA funds can cover PlexusDx medications, providing tax advantages
If skin sensitivity continues, discontinue use
Whether youre spraying fields, mapping terrain, or conducting surveillance, Cebattery has the energy to keep you flying longer
GLP-1 medications work on brain reward pathways and appetite centres, potentially reducing food cravings and loss-of-control eating beyond simple hunger suppression